News & Updates
Filter by Specialty:

Vitamin D deficiency tied to higher T2D risk
Increased serum concentration of 25(OH)D appears to contribute to a reduced risk of type 2 diabetes (T2D) across the glycaemic spectrum below the threshold for diabetes, reports a study. Improving the lipid profile may be partly responsible for the favourable association.
Vitamin D deficiency tied to higher T2D risk
09 Sep 2024
SGLT-2 inhibitors may prevent dementia in adults with T2D
Initiation of sodium-glucose cotransporter-2 (SGLT-2) inhibitors results in a 35-percent reduced risk of dementia compared with dipeptidyl peptidase-4 (DPP-4) inhibitors in individuals with type 2 diabetes (T2D) aged 40–69 years, according to a study. In addition, greater benefits are seen with longer treatment duration.
SGLT-2 inhibitors may prevent dementia in adults with T2D
07 Sep 2024
Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis
Data from the Hong Kong Childhood Diabetes Registry (HKCDR) show that 2 years after diagnosis of paediatric type 2 diabetes mellitus (T2DM), approximately 20–65 percent of patients have ≥1 of the following: microalbuminuria (MA), suboptimal glycaemic control, hypertension, or dyslipidaemia.
Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis
06 Sep 2024
In Asia, being heavier takes a toll on CRC incidence, mortality
A strong, positive link between BMI and the risk of colorectal cancer (CRC) incidence and related deaths has been found in Asian populations.
In Asia, being heavier takes a toll on CRC incidence, mortality
02 Sep 2024
Empagliflozin reduces hepatic fat content in nondiabetic MASLD patients
Empagliflozin significantly reduces hepatic fat content vs placebo in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) without diabetes, researchers from the University of Hong Kong have reported.